CC
MEDP icon

Centiva Capital’s Medpace MEDP Stock Holding History

Centiva Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,842
Closed -$578K – 1547
2025
Q2 		$578K Sell
1,842
-2,819
-60% -$846K 0.01% 897
2025
Q1 		$1.42M Buy
+4,661
New +$1.57M 0.04% 304
2024
Q4 		– Sell
-4,842
Closed -$1.62M – 2116
2024
Q3 		$1.62M Buy
+4,842
New +$1.84M 0.03% 558
2024
Q2 		– Sell
-2,782
Closed -$1.12M – 2332
2024
Q1 		$1.12M Buy
2,782
+48
+2% +$16.9K 0.03% 612
2023
Q4 		$838K Buy
2,734
+438
+19% +$118K 0.02% 699
2023
Q3 		$556K Sell
2,296
-18,830
-89% -$4.82M 0.01% 914
2023
Q2 		$5.07M Buy
+21,126
New +$4.39M 0.11% 174
2022
Q4 		– Sell
-1,700
Closed -$267K – 1521
2022
Q3 		$267K Buy
+1,700
New +$271K 0.01% 1089
2021
Q3 		– Sell
-2,068
Closed -$365K – 1487
2021
Q2 		$365K Buy
+2,068
New +$357K 0.01% 973

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Centiva Capital's MEDP Position: Q3 2025 in Review

Centiva Capital sold out of Medpace (MEDP) in Q3 2025, closing a stake of 1,842 shares — an estimated $578K sold.

Centiva Capital first reported a position in MEDP in Q2 2021 and held it in 9 quarters. The position peaked at $5.07M in Q2 2023. 673 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Centiva Capital reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 1,842 Medpace shares in Q3 2025, an estimated $578K.
  • Centiva Capital first reported a position in Medpace in Q2 2021 and held it in 9 quarters.
  • Centiva Capital's Medpace position peaked at $5.07M in Q2 2023.
  • 673 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.